Method of synthesizing a fluoride growth material for improved outgassing
    51.
    发明申请
    Method of synthesizing a fluoride growth material for improved outgassing 审中-公开
    合成氟化物生长材料以改进除气的方法

    公开(公告)号:US20060249072A1

    公开(公告)日:2006-11-09

    申请号:US11122703

    申请日:2005-05-05

    摘要: Improved contaminant removal from alkaline- or alkali-earth metal fluoride crystal growth material can be obtained by coprecipitating an alkaline- or alkali-earth metal fluoride with a scavenging agent during synthesis of the fluoride growth material. The coprecipitation of the alkaline- or alkali-earth metal fluoride and scavenging agent can be performed using at least one of chloride, nitrate, hydroxide and carbonate salts of the alkaline- or alkali-earth metal fluoride and scavenging agent. This provides a more intimate mixture or dispersion of the scavenging agent in solid solution or as a mechanical mixture with the alkaline- or alkali-earth metal fluoride for improved outgassing and fewer trapped impurities, leading to improved radiation hardness and bulk absorption.

    摘要翻译: 通过在合成氟化物生长材料期间用清除剂共沉淀碱金属或碱土金属氟化物,可以获得从碱金属或碱土金属氟化物晶体生长材料中去除改进的污染物。 碱金属或碱土金属氟化物和清除剂的共沉淀可以使用碱金属或碱土金属氟化物和清除剂中的至少一种氯化物,硝酸盐,氢氧化物和碳酸盐来进行。 这提供了清除剂在固溶体中或作为与碱土金属或碱土金属氟化物的机械混合物的更加密切的混合物或分散体,用于改善除气和较少的捕获的杂质,导致改进的辐射硬度和体积吸收。

    Formulation for corrosion and scale inhibition
    53.
    发明申请
    Formulation for corrosion and scale inhibition 审中-公开
    腐蚀和阻垢制剂

    公开(公告)号:US20060180789A1

    公开(公告)日:2006-08-17

    申请号:US10550156

    申请日:2004-03-18

    IPC分类号: C02F5/10

    CPC分类号: C02F5/14 C02F2305/04

    摘要: A formulation comprising a THP+salt and a thio-substituted compound. The formulation is suitable for use in the treatment of corrosion and metal sulphide scale deposits in aqueous systems. The thio-substituted compound may be a thio-substituted carboxylic acid or salt, a thio-substituted sulphonic acid, a substituted or unsubstituted alkyl or aryl thiol, a thio-substituted heterocyclic compound or a mercaptoethanol.

    摘要翻译: 包含THP + +盐和硫代取代的化合物的制剂。 该配方适用于处理含水体系中的腐蚀和金属硫化物垢沉积物。 硫代取代的化合物可以是硫代取代的羧酸或盐,硫取代的磺酸,取代或未取代的烷基或芳基硫醇,硫取代的杂环化合物或巯基乙醇。

    Microprocessor with branch target determination in decoded microinstruction code sequence
    56.
    发明申请
    Microprocessor with branch target determination in decoded microinstruction code sequence 审中-公开
    微处理器在解码微指令代码序列中具有分支目标确定

    公开(公告)号:US20060015708A1

    公开(公告)日:2006-01-19

    申请号:US10891166

    申请日:2004-07-14

    IPC分类号: G06F9/00

    CPC分类号: G06F9/3017 G06F9/3808

    摘要: In a microprocessor, customer code routines are decoded from ISA instructions into microinstructions and stored in a customer code store (CCS) for later, repeated execution. Branch target addresses in the ISA code, which use an ISA memory addressing format, are replaced with CCS branch target addresses in the decoded, stored customer code routine. The customer code routine thus behaves as a microcoded library routine.

    摘要翻译: 在微处理器中,客户代码例程从ISA指令被解码为微指令,并存储在客户代码存储(CCS)中以供稍后重复执行。 使用ISA存储器寻址格式的ISA代码中的分支目标地址在解码的存储的客户代码例程中被CCS分支目标地址替换。 因此,客户代码例程作为微编码库例程。

    Blood testing and therapeutic compound delivery system
    59.
    发明申请
    Blood testing and therapeutic compound delivery system 审中-公开
    血液检测和治疗复合物输送系统

    公开(公告)号:US20050261561A1

    公开(公告)日:2005-11-24

    申请号:US11134221

    申请日:2005-05-20

    IPC分类号: A61B5/00 A61K38/28 A61M5/172

    摘要: A system and method are provided for determining intravenous blood levels of a target compound contained in a blood vessel of a patient. The method includes the operation of detecting concentrations of the target compound within a patient's blood using a sensor device configured to optically test blood at a location within the blood vessel. Another operation is calculating a measured amount of a therapeutic compound to administer into the patient's bloodstream based on the concentrations of the target compound in the blood. The measured amount of therapeutic compound may then be pumped through the catheter into the patient's blood.

    摘要翻译: 提供了一种用于确定包含在患者的血管中的目标化合物的静脉内血液水平的系统和方法。 该方法包括使用构造成在血管内的位置光学测试血液的传感器装置来检测患者血液中目标化合物的浓度的操作。 另一个操作是根据血液中目标化合物的浓度来计算测量量的施用于患者血液中的治疗化合物。 然后将测量的治疗化合物的量通过导管泵送到患者的血液中。